We have produced antipodoplanin (PDPN) cancer-specific mAbs (CasMabs), clone LpMab-2(8,9) and LpMab-23,(10,11) which specifically recognize cancer-type PDPN in tumor tissues. The gene discussed is PDPN; the disease is cancer.